<ѻýҕl>Cath Lab Recap: Killer Pacemakers; Heart Monitoring Underwearѻýҕl> Interventional cardiology news to note Dec 08, 2016
<ѻýҕl>Amyloidosis Treatments Miss the Heart of the Problemѻýҕl> Only modest improvement in end organ function Dec 07, 2016
<ѻýҕl>CMS to Offer Billing Code for Heart Failure Specialistsѻýҕl> Should eliminate denials for appearance of double-billing Dec 02, 2016
<ѻýҕl>After Tamponade, Pericardial Drain Removal Safe Once Dryѻýҕl> At one center, no advantage seen to keeping them in longer Nov 30, 2016
<ѻýҕl>CardioBrief: Prenatal Genetic Test Billing Practices Questionedѻýҕl> Insurance billed $2,760, but is the "real" bill $200? Nov 29, 2016
<ѻýҕl>Oral Treatment for T2D Tied to Renal Protectionѻýҕl> SGLT2 inhibitor shows favorable effect on eGFR Nov 22, 2016
<ѻýҕl>Trial: No Benefit for High-Dose Diuretic in Acute HFѻýҕl> But phase II results might not be the final word Nov 17, 2016
<ѻýҕl>AHA: Mixed Results For ApoA-1 Therapiesѻýҕl> But it's still not time to write the obituary for all HDL therapies Nov 16, 2016
<ѻýҕl>AHA: No Pump Thrombosis With Next-Gen LVAD?ѻýҕl> Better outcomes in HeartMate 3 trial hinged on fewer malfunctions Nov 16, 2016
<ѻýҕl>CardioBrief: Is the American Heart Association Trying to Kill Reporters?ѻýҕl> Margarine and skim milk in the press room beg the question Nov 15, 2016
<ѻýҕl>AHA: Unnecessary Stress Testing Still Alive And Kicking?ѻýҕl> More tests given to younger patients in large population study Nov 15, 2016
<ѻýҕl>AHA: Lower Better for Plaque Regression with PCSK9 Drugsѻýҕl> No diminishing returns at very low LDL levels in GLAGOV trial Nov 15, 2016
<ѻýҕl>AHA: Real World TAVR Is All About Patient Selectionѻýҕl> Intermediate risk is a moving target Nov 15, 2016
<ѻýҕl>Statin 'Census' Shows Major Disparitiesѻýҕl> Women, minorities treated at significantly lower rates Nov 14, 2016
<ѻýҕl>AHA: Healthy Lifestyle Eases Heart Impact of High Genetic Riskѻýҕl> Fewer adverse events, less calcification in pooled data Nov 13, 2016
<ѻýҕl>AHA: No Cognitive Benefit from Heart Drugs in HOPE-3ѻýҕl> Substudy finds mental function unimproved by BP, cholesterol treatments Nov 13, 2016 video
<ѻýҕl>AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilatorѻýҕl> Investigational drug ularitide had no effect on mortality or clinical outcomes Nov 13, 2016
<ѻýҕl>AHA: Study Finds Celebrex Safe for Heartѻýҕl> But naproxen not as heart safe as believed Nov 13, 2016 video
<ѻýҕl>TCT: Orsiro No Better Than EES for CTOѻýҕl> Also, injectable collagenase eases PCI for CTO in trial Nov 04, 2016
<ѻýҕl>TCT: Amulet LAA Occluder Hot on the Heels of Watchmanѻýҕl> Another LAA closure device shows favorable results in trial Nov 03, 2016
<ѻýҕl>TCT: Novel Drug-Coated Balloon Promising for Peripheryѻýҕl> Stellarex beat angioplasty alone in fairly complex PAD population trial Nov 03, 2016
<ѻýҕl>Aneurysm Sealing Device Hits Hurdlesѻýҕl> Migration, endoleaks, and aneurysm growth cited for novel Nellix device Nov 02, 2016
<ѻýҕl>TCT: TAVR Holds Up Pretty Well Over Timeѻýҕl> Also, 2-year data confirm lasting improvements in QoL Nov 02, 2016
<ѻýҕl>TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane?ѻýҕl> FDA Commissioner and E.U. representative talk change Nov 02, 2016
<ѻýҕl>TCT: Embolic Protection Flops for TAVRѻýҕl> New brain lesions or clinical strokes unaffected in SENTINEL trial Nov 01, 2016
<ѻýҕl>TCT: Trials Split on PCI vs CABG for Left Main Diseaseѻýҕl> NOBLE hands advantage to surgery, EXCEL finds noninferiority Oct 31, 2016
<ѻýҕl>TCT: Advantage of Novel DES Over BMS Grows With Timeѻýҕl> For high bleeding risk patients, rationale for BMS continues to shrink Oct 30, 2016
<ѻýҕl>CardioBrief: Impella No Better Than IABP in Cardiogenic Shockѻýҕl> Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016
<ѻýҕl>TCT: OCT Guidance Doesn't Undersize Stents, Trial Showsѻýҕl> Also found dissection, malapposition that IVUS missed Oct 30, 2016
<ѻýҕl>Treadmill Test Scoring Better With Gender as a Factorѻýҕl> New sex-specific score predicted women's mortality more accurately Oct 26, 2016 video
<ѻýҕl>FDA Warns of Testosterone Abuseѻýҕl> Adverse events tied to abuse include heart attack, heart failure, and stroke Oct 25, 2016
<ѻýҕl>U.S. Obesity Crisis: Is the Wrong Omega-X Mix Responsible?ѻýҕl> Ratio of omega-6 to omega-3 in Western diet is 16:1 Oct 25, 2016
<ѻýҕl>Pearls From: Roxana Mehran, MDѻýҕl> Interventional cardiologist discusses acute kidney injury reduction Oct 14, 2016 video
<ѻýҕl>FDA Warns on Cardiac Surgery Heater-Cooler Deviceѻýҕl> Cites mycobacterial contamination risk Oct 13, 2016
<ѻýҕl>CardioBrief: LDL-Lowering Genetic Variants Linked to Diabetes Riskѻýҕl> What can genetics tell about diabetes incidence with cholesterol tx? Oct 06, 2016
<ѻýҕl>CardioBrief: Trump's CV Event Risk Seven Times Bigger Than Clinton'sѻýҕl> Cardiologist speculates on coronary calcium scores disclosed by the candidates Oct 05, 2016
<ѻýҕl>Billion Dollar Lab Scam: The Beat Goes Onѻýҕl> Yet more fallout from the catastrophic bankruptcy of HDL Lab Sep 22, 2016
<ѻýҕl>Slow Medicine: Is 'Hypertensive Urgency' Outdated?ѻýҕl> No need to over-react to a common dx that's not tied to major CV events Sep 22, 2016
<ѻýҕl>HFSA: Clinical Benefits Tied To Lung Monitoring Persistѻýҕl> HF rehospitalization, deaths remain reduced up to 4.5 years Sep 21, 2016
<ѻýҕl>Cardiac Myosin Activator Shows Promise for LV Functionѻýҕl> 'More hands pulling on the rope' Sep 21, 2016